Bonanza Creek Energy Announces Agreement on Comprehensive Deleveraging and Recapitalization
Dec 23, 2016 13:25 pm UTC| Business
BONANZA CREEK ENTERS INTO RESTRUCTURING SUPPORT AGREEMENT WITH BONDHOLDERS HOLDING MORE THAN $400MILLIONIN UNSECURED DEBTBONANZA CREEK’S DEBT TO BE REDUCED BY MORE THAN $850 MILLION CERTAINBONDHOLDERSCOMMIT TO PROVIDENEW...
Sighthound Unveils Sighthound Video 4.0
Dec 23, 2016 13:15 pm UTC| Business
Artificial intelligence surveillance software for the home now with audio, better human detection and higher quality video PALO ALTO, Calif., Dec. 23, 2016 -- Sighthound, Inc. today announced the release of Sighthound...
Dec 23, 2016 13:09 pm UTC| Business
Acquisition Expands Descartes’ Content Solutions with Comprehensive Logistics Trade Data WATERLOO, Ontario, Dec. 23, 2016 -- Descartes Systems Group (TSX:DSG) (Nasdaq:DSGX), the global leader in uniting...
Strongbridge Biopharma plc Provides Corporate and Financial Update
Dec 23, 2016 13:03 pm UTC| Business
~ Expands Rare Disease Portfolio through Acquisition of U.S. Rights to KEVEYIS®, the First and Only FDA-Approved Treatment for Hyperkalemic, Hypokalemic, and Related Variants of Primary Periodic Paralysis ~ ~ Provides...
Strongbridge Biopharma plc Announces Acquisition of U.S. Rights to KEVEYIS® From Taro
Dec 23, 2016 13:01 pm UTC| Business
~ KEVEYIS is the First and Only FDA-Approved Treatment for Hyperkalemic, Hypokalemic, and Related Variants of Primary Periodic Paralysis, an Ultra-Orphan, Genetic Neuromuscular Disease ~ ~ KEVEYIS is Strongbridge’s First...
Strongbridge Biopharma plc Announces $35 Million Equity Financing
Dec 23, 2016 13:00 pm UTC| Business
DUBLIN, Ireland and TREVOSE, Pa., Dec. 23, 2016 -- Strongbridge Biopharma plc, (Nasdaq:SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare...
Dec 23, 2016 13:00 pm UTC| Business
SAN DIEGO, Dec. 23, 2016 -- Neothetics, Inc. (NASDAQ:NEOT) today announced the initiation of the Phase 2 proof of concept trial, LIPO-202-CL-31, for LIPO-202 for the reduction of submental subcutaneous fat. “The...